|
Release of Final Report
Senator the Hon Kim Carr issued a media release to announce the release of the Final Report of the Pharmaceuticals Industry Strategy Group (the PISG) on Friday 30 January 2009. Download the Final Report as a  PDF (3,697 KB) or an  RTF (1.17 MB). The Executive Summary is available as a PDF (912 KB).
|
On 26 May 2008, the Minister for Innovation, Industry, Science and Research, Senator the Hon Kim Carr issued a media release to announce the 
terms of reference [PDF 16 KB] for the PISG.
The PISG was tasked with examining the drivers and barriers to attracting new internationally competitive and sustainable manufacturing, R&D and clinical trials investment in the pharmaceuticals sector.
The PISG was co-chaired by Dr Brian McNamee, the Chief Executive Officer and Managing Director of CSL and Mr Craig Pennifold, the Head of the Innovation Division, within the Department of Innovation, Industry, Science and Research.
On 20 October 2008, the Minister issued a media release about the PISG's Directions Paper [PDF 407 KB]. The PISG then consulted more broadly and refined its proposals to produce a Final Report.
The PISG provided its Final Report to the Minister in December 2008. The Final Report provides an overview of the Australian and global pharmaceuticals industries, a discussion of the barriers and drivers to investment in the Australian industry, and explores a strategic framework to secure a sustainable future that will deliver a net benefit to Australia.
A copy of the Final Report [PDF 3,697 KB] is available here. A copy of the Executive Summary [PDF 912 KB] is available here. The Final Report is also available as an RTF document [1.17 MB].
The PISG was comprised of key industry and union leaders. It met six times: on 7 July, 11 August, 19 September, 24 October, 19 November and 5 December 2008.
Members of the PISG
|
Name |
Position |
Organisation |
|
Dr Brian McNamee, AO (Co‑Chair) |
Chief Executive Officer and Managing Director |
CSL Limited |
|
Mr Craig Pennifold (Co‑Chair) |
Head of Innovation Division |
Department of Innovation, Industry, Science and Research |
| Mr Nixon Apple |
Industry and Economic Adviser |
Australian Manufacturing Workers Union |
|
Dr Graeme Blackman |
Managing Director |
Institute of Drug Technology Limited |
|
Mr Dan Brown |
Managing Director |
Genzyme Australasia Pty Ltd |
|
Mr Ian Chalmers |
Chief Executive Officer |
Medicines Australia |
|
Dr Greg R Collier |
CEO and Managing Director |
ChemGenex Pharmaceuticals Limited |
|
Mr Peter Cook |
CEO and Managing Director |
Biota Holdings Limited |
|
Mr Richard Davies |
then Managing Director |
Amgen Australia Pty Ltd
|
|
Mr Joe de Bruyn |
National Secretary and Treasurer |
Shop, Distributive and Allied Employees Union |
|
Mr Will Delaat |
Chair |
Pharmaceuticals Industry Council |
|
Mr Charlie Donnelly |
National Secretary |
National Union of Workers |
|
Ms Cait O'Connor |
National Policy and Research Officer |
Australian Workers' Union |
|
Ms Alison Finger |
then Managing Director |
Bristol-Myers Squibb Australia Pty Ltd |
|
Ms Di Ford |
then Executive Director |
Generic Medicines industry Association
|
|
Mr Mitch Kirkman |
Manager - Process, Training and Quality |
Novartis Pharmaceuticals Australia Pty Ltd |
|
Mr John Latham |
Regional Director |
Pfizer Australia / Pfizer New Zealand |
|
Dr Anna Lavelle |
Chief Executive Officer |
AusBiotech Ltd |
|
Professor Graham Macdonald |
Chair |
Pharmaceuticals Education Council |
|
Mr John Montgomery |
Chief Executive Officer |
Alphapharm |
|
Dr Tim Oldham |
President, Asia Pacific |
Hospira |
|
Dr Alan Robertson |
Chief Executive Officer |
Pharmaxis Ltd |
|
Dr Merilyn Sleigh |
Chief Executive Officer |
InAvanti |
|
Mr Ken Windle |
Chairman & CEO |
Advent Pharmaceuticals |
For more information about the Pharmaceuticals Industry Strategy Group please contact:
The Pharmaceuticals Industry Strategy Group Secretariat
Department of Innovation, Industry, Science and Research
GPO Box 9839
CANBERRA ACT 2601
Australia
Tel: +61 2 6213 6187
Email